Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recruiting × ferric derisomaltose × Clear all

Phase

Status

Unknown 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Anemia, Iron-Deficiency 1 Anemia 1

Interventions

Cisplatin 85 Carboplatin 81 pembrolizumab 78 Gemcitabine 67 Paclitaxel 66 Docetaxel 61 Capecitabine 47 Oxaliplatin 44 Fluorouracil 44 Radiotherapy 43 Specimen Handling 42 Bevacizumab 40 Magnetic Resonance Spectroscopy 38 Pemetrexed 35 Dexamethasone 35 Cyclophosphamide 35 Drug Therapy 34 Leucovorin 32 Doxorubicin 31 Irinotecan 30 Rituximab 26 Lenalidomide 25 Injections 25 Vincristine 23 Trastuzumab 23 Radiosurgery 21 Radiation 20 Prednisone 20 toripalimab 19 Radiotherapy, Intensity-Modulated 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05407987 2025-04-25

FORGE II

AHS Cancer Control Alberta

Phase 3 Recruiting

Classical hematology

Anemia, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡